MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers.

Wyce, Anastasia; Matteo, Jeanne J; Foley, Shawn W; Felitsky, Daniel J; Rajapurkar, Satyajit R; Zhang, Xi-Ping; Musso, Melissa C; Korenchuk, Susan; Karpinich, Natalie O; Keenan, Kathryn M; Stern, Melissa; Mathew, Lijoy K; McHugh, Charles F; McCabe, Michael T; Tummino, Peter J; Kruger, Ryan G; Carpenter, Christopher; Barbash, Olena

Wyce, Anastasia; Matteo, Jeanne J; Foley, Shawn W; Felitsky, Daniel J; Rajapurkar, Satyajit R; Zhang, Xi-Ping; Musso, Melissa C; Korenchuk, Susan; Karpinich, Natalie O; Keenan, Kathryn M; Stern, Melissa; Mathew, Lijoy K; McHugh, Charles F; McCabe, Michael T; Tummino, Peter J; Kruger, Ryan G; Carpenter, Christopher; Barbash, Olena.

Afiliação

Wyce A; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Matteo JJ; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Foley SW; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Felitsky DJ; Target Sciences, GlaxoSmithKline, Upper Merion, PA, USA.
Rajapurkar SR; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Zhang XP; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Musso MC; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Korenchuk S; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Karpinich NO; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Keenan KM; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Stern M; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Mathew LK; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
McHugh CF; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
McCabe MT; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Tummino PJ; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Kruger RG; Janssen Pharmaceuticals, Spring House, Montgomery, PA, USA.
Carpenter C; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.
Barbash O; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.

Oncogenesis ; 7(4): 35, 2018 Apr 20.

Article em En | MEDLINE | ID: mdl-29674704

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos